Sage Journals: Discover world-class research

Open access

Review article

First published 2025

Plain language summary of publication of new targets in diabetic retinopathy including a protein called semaphorin 3A: addressing limitations of current treatments

Sobha Sivaprasad, Randall Barker, Nina Zippel

Therapeutic Advances in Ophthalmology

Retricted access

Research article

First published 2015-11

Expression of semaphorin 3A,semaphorin 7A and their receptors in multiple sclerosis lesions

C Costa, E Martínez-Sáez, A Gutiérrez-Franco [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2021-11

Immunosuppressive Regulation of Dendritic Cells and T Cells in Allergic Rhinitis by Semaphorin 3A

Honghui Liu, Jinye Xia, Yu Chen [...]

American Journal of Rhinology & Allergy

Retricted access

Research article

First published 2016-10

Semaphorin 3A Induces Odontoblastic Phenotype in Dental Pulp Stem Cells

S. Yoshida, N. Wada, D. Hasegawa [...]

Journal of Dental Research

Retricted access

Research article

First published 2010-07

Galectin-1 and Semaphorin-3A Are Two Soluble Factors Conferring T-Cell Immunosuppression to Bone Marrow Mesenchymal Stem Cell

Yves Lepelletier, Séverine Lecourt, Amédée Renand [...]

Stem Cells and Development

Retricted access

Research article

First published 2014-09

Semaphorin 3A Induces Mesenchymal-Stem-Like Properties in Human Periodontal Ligament Cells

Naohisa Wada, Hidefumi Maeda, Daigaku Hasegawa [...]

Stem Cells and Development

Retricted access

Review article

First published 2012-10

Semaphorin 3A – a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus

Z Vadasz, E Toubi

Lupus

Retricted access

Research article

First published 2022-5

Local treatment with Sema3a could promote the osseointegration of hydroxyapatite coated titanium rod in diabetic rats

Zhengyu Wang, Shan Wei

Journal of Biomaterials Applications

Open access

Research article

First published 2022-12

Assessment of Serum Semaphorin-3A Level in Systemic Lupus Erythematosus Patients in Suez Canal Region

Alaa Saber Shams, Nevene Ramsis Wissa, Mai Mohamed Abdelnaby [...]

Indian Journal of Rheumatology

Retricted access

Editorial

First published 2015-11

Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice,rats and men

David Kremer, Hans-Peter Hartung, Patrick Küry

Multiple Sclerosis Journal

Search results